🟢 Citius Pharmaceuticals is trading 10.3% up today, extending a two-day rally following its recent earnings report

Citius Pharmaceuticals is trading 10.3% up today at $0.63, extending a sharp two-day rally from $0.50 as momentum continues to build.

• The upward move follows the company’s fiscal Q2 2026 report, which highlighted $5.6 million in revenue from LYMPHIR and the securing of new financings.
• Although there are no fresh company-specific headlines today, the stock is benefiting from a broadly positive market backdrop and continued investor reaction to recent financial milestones.